Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Preimplantation Genetics Diagnosis (PGD) Market, by Test Type
1.4.2 North America Preimplantation Genetics Diagnosis (PGD) Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type
3.1 North America Aneuploidy Market by Country
3.2 North America Chromosomal Abnormalities Market by Country
3.3 North America X-linked diseases Market by Country
3.4 North America Single Gene Disorders Market by Country
3.5 North America HLA Typing Market by Country
3.6 North America Gender selection Market by Country
3.7 North America Other Test Type Market by Country
Chapter 4. North America Preimplantation Genetics Diagnosis (PGD) Market by Country
4.1 US Preimplantation Genetics Diagnosis (PGD) Market
4.1.1 US Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2 Canada Preimplantation Genetics Diagnosis (PGD) Market
4.2.1 Canada Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3 Mexico Preimplantation Genetics Diagnosis (PGD) Market
4.3.1 Mexico Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market
4.4.1 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type
Chapter 5. Company Profiles
5.1 Illumina, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.2 Invitae Corporation
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expenses
5.3 Natera Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expenses
5.4 Agilent Technologies, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent Strategies and Developments:
5.4.5.1 Approvals and Trials:
5.5 PerkinElmer, Inc.
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expense
5.5.5 Recent Strategies and Developments:
5.5.5.1 Product Launches and Product Expansions:
5.6 Quest Diagnostics Incorporated
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental Analysis
5.7 Reproductive Genetic Innovations
5.7.1 Company Overview
5.8 PacGenomics
5.8.1 Company Overview
5.9 CeGaT GmbH
5.9.1 Company Overview
5.10. Laboratory Corporation of America Holdings
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
Unique Offerings 